Computed tomographic scan-diagnosed chronic obstructive pulmonary disease-emphysema: Eotaxin-1 is associated with bronchodilator response and extent of emphysema

Journal of Allergy and Clinical Immunology

Volumn 120, Issue 5, 2007, Pages 1118-1125

  Miller, Marina ^a   Ramsdell, Joe ^a   Friedman, Paul J ^b   Cho, Jae Youn ^a   Renvall, Marian ^a   Broide, David H ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Asthma; chemokines; cytokines; eosinophil; eotaxin

Indexed keywords

BIOLOGICAL MARKER; CARBON MONOXIDE; CHEMOKINE; EOTAXIN; IMMUNOGLOBULIN E;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; BLOOD LEVEL; BREATH ANALYSIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIFFUSION; DISEASE ASSOCIATION; EMPHYSEMA; EOSINOPHIL; FEMALE; HUMAN; LUNG FUNCTION; LUNG LAVAGE; MALE; PRIORITY JOURNAL;

AGED; BIOLOGICAL MARKERS; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHODILATOR AGENTS; CHEMOKINE CCL11; CHEMOKINE CCL5; EOSINOPHIL CATIONIC PROTEIN; FEMALE; HUMANS; IMMUNOGLOBULIN E; MALE; MIDDLE AGED; NEUTROPHILS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY EMPHYSEMA; TOMOGRAPHY, X-RAY COMPUTED;

EID: 35648937579     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2007.08.045     Document Type: Article

References (20)

1. Barnes P.J. Chronic obstructive pulmonary disease. N Engl J Med 343 (2000) 269-280
2. Busse W.W., and Lemanske Jr. R.F. Asthma. N Engl J Med 344 (2001) 350-362
3. Anthonisen N.R., and Wright E.C. Bronchodilator response in chronic obstructive pulmonary disease. Am Rev Respir Dis 133 (1986) 814-819
4. Fabbri L.M., Romagnoli M., Corbetta L., Casoni G., Busljetic K., Turato G., et al. Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease. Am J Respir Crit Care Med 167 (2003) 418-424
5. ten Brinke A., Zwinderman A.H., Sterk P.J., Rabe K.F., and Bel E.H. Factors associated with persistent airflow limitation in severe asthma. Am J Respir Crit Care Med 164 (2001) 744-748
6. Vonk J.M., Jongepier H., Panhuysen C.I., Schouten J.P., Bleecker E.R., and Postma D.S. Risk factors associated with the presence of irreversible airflow limitation and reduced transfer coefficient in patients with asthma after 26 years of follow up. Thorax 58 (2003) 322-327
7. Brightling C.E., Monteiro W., Ward R., Parker D., Morgan M.D., Wardlaw A.J., et al. Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial. Lancet 356 (2000) 1480-1485
8. Papi A., Romagnoli M., Baraldo S., Braccioni F., Guzzinati I., Saetta M., et al. Partial reversibility of airflow limitation and increased exhaled NO and sputum eosinophilia in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 162 (2000) 1773-1777
9. Vignola A.M., Paganin F., Capieu L., Scichilone N., Bellia M., Maakel L., et al. Airway remodelling assessed by sputum and high-resolution computed tomography in asthma and COPD. Eur Respir J 24 (2004) 910-917
10. Pauwels R.A., Buist A.S., Ma P., Jenkins C.R., Hurd S.S., and GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: National Heart Lung, and Blood Institute and World Health Organization Global Initiative for Chronic Obstructive Lung Disease (GOLD); executive summary. Respir Care 46 (2001) 798-825
11. Jones P.W., Quirk F.H., Baveystock C.M., and Littlejohns P. A self complete measure of health status of chronic airflow limitation. The St Georges Respiratory Questionnaire. Am Rev Respir Dis 145 (1992) 1321-1327
12. Müller N.L., Staples C.A., Miller R.R., and Abboud R.T. Density mask. An objective method to quantitate emphysema using computed tomography. Chest 94 (1988) 782-787
13. The American Thoracic Society. Standardization of spirometry-1987 update. Statement. Am Rev Respir Dis 136 (1987) 1285-1298
14. Verebey K.G., DePace A., Mulé S.J., Kanzler M., and Jaffe J.H. A rapid quantitative GLC method for the simultaneous determination of nicotine and cotinine. J Anal Toxicol 6 (1982) 294-296
15. Broide D.H., Paine M.M., and Firestein G.S. Eosinophils express interleukin 5 and granulocyte macrophage-colony-stimulating factor mRNA at sites of allergic inflammation in asthmatics. J Clin Invest 90 (1992) 1414-1424
16. Cho J.Y., Miller M., Baek K.J., Han J.W., Nayar J., Lee S.Y., et al. Inhibition of airway remodeling in IL-5-deficient mice. J Clin Invest 113 (2004) 551-560
17. Sur S., Gleich G.J., Swanson M.C., Bartemes K.R., and Broide D.H. Eosinophilic inflammation is associated with elevation of interleukin-5 in the airways of patients with spontaneous symptomatic asthma. J Allergy Clin Immunol 96 (1995) 661-668
18. Miotto D., Christodoulopoulos P., Olivenstein R., Taha R., Cameron L., Tsicopoulos A., et al. Expression of IFN-gamma-inducible protein; monocyte chemotactic proteins 1, 3, and 4; and eotaxin in TH1- and TH2-mediated lung diseases. J Allergy Clin Immunol 107 (2001) 664-670
19. Blanchard C., Wang N., Stringer K.F., Mishra A., Fulkerson P.C., Abonia J.P., et al. Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis. J Clin Invest 116 (2006) 536-547
20. Perng D.W., Huang H.Y., Chen H.M., Lee Y.C., and Perng R.P. Characteristics of airway inflammation and bronchodilator reversibility in COPD. A potential guide to treatment. Chest 126 (2004) 375-381